로딩 중…
StockDiggingStockDigging

SELVAS Healthcare, Inc.

208370· KOSDAQ
₩3,065-5.69%
2026-06-19

Price Chart

SELVAS Healthcare, Inc.-38.02%

Financials

Investment Metrics(as of 2026-06-19)

MetricValue
Size
Market Cap78.89B KRW
Revenue30.19B KRW
Net Income3.64B KRW
Total Assets92.20B KRW
Net Assets84.43B KRW
Employees132
Value
P/E21.66x
P/B0.93x
PEG0.00x
P/S2.61x
EV/EBITDA254.17x
FCF Yield-0.70%
Profitability
ROE4.31%
ROA3.95%
Op. Margin0.99%
Revenue Growth-8.76%
Earnings Growth6714.74%
Financial Health
Debt Ratio109.20%
Total Debt749.9M KRW
FCF-552.0M KRW
Cash4.00B KRW
Current Ratio11.96x
Net Debt/EBITDA-10.91x
Performance
1Y Return-38.02%
1M Return-16.03%
From 52W High-59.08%
1Y MDD-55.26%
Trading
Volume200,471 shares
Foreign Own.2.31%
Per Share
EPS657 KRW
BPS3,283 KRW

Company Info

CEO 유병탁
Employees 132
Founded 2014
HQ 대전광역시 유성구, KR

Selvas Healthcare was established in 1999 to develop and sell medical diagnostic devices and visual assistive technology devices, enhancing its technological capabilities through a 2015 merger with Jawon Medical. The company operates two divisions: Accuniq, for body composition analyzers and automatic blood pressure monitors, and Himss, which produces braille information terminals and reading magnifiers for the visually impaired. Leveraging 30 years of technological expertise, Selvas Healthcare is growing as a specialized digital healthcare company, expanding into international markets via partnerships with fitness distribution channels. Selvas Healthcare was established in 2014 and is headquartered in Yuseong-gu, Daejeon.